Perspectives on Anti-Glycan Antibodies Gleaned from Development of a Community Resource Database

Antibodies are used extensively for a wide range of basic research and clinical applications. While an abundant and diverse collection of antibodies to protein antigens have been developed, good monoclonal antibodies to carbohydrates are much less common. Moreover, it can be difficult to determine if a particular antibody has the appropriate specificity, which antibody is best suited for a given application, and where to obtain that antibody. Herein, we provide an overview of the current state of the field, discuss challenges for selecting and using antiglycan antibodies, and summarize deficiencies in the existing repertoire of antiglycan antibodies. This perspective was enabled by collecting information from publications, databases, and commercial entities and assembling it into a single database, referred to as the Database of Anti-Glycan Reagents (DAGR). DAGR is a publicly available, comprehensive resource for anticarbohydrate antibodies, their applications, availability, and quality.

• Publication year

  2016

• Venue

  ACS Chemical Biology

• Publication date

  2016-05-25

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/acschembio.6b00244PMID 27220698PMCID 4949583
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Order out of chaos.

  2017cited by this paper
• Diverse molecular recognition properties of blood group A binding monoclonal antibodies.

  2016cited by this paper
• Generation of Monoclonal Antibodies against Defined Oligosaccharide Antigens.

  2015cited by this paper
• Deciphering the Non-Equivalence of Serine and Threonine O-Glycosylation Points: Implications for Molecular Recognition of the Tn Antigen by an anti-MUC1 Antibody**

  2015cited by this paper
• Fluorous-Assisted Chemoenzymatic Synthesis of Heparan Sulfate Oligosaccharides

  2014cited by this paper
• Immature truncated O-glycophenotype of cancer directly induces oncogenic features

  2014cited by this paper
• Cross-platform comparison of glycan microarray formats.

  2014cited by this paper
• Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers.

  2014cited by this paper
• Key role for myeloid cells: Phase II results of anti‐GD2 antibody 3F8 plus granulocyte‐macrophage colony‐stimulating factor for chemoresistant osteomedullary neuroblastoma

  2014cited by this paper
• FGF-FGFR signaling mediated through glycosaminoglycans in microtiter plate and cell-based microarray platforms.

  2013cited by this paper
• Chemoenzymatic synthesis of glycosaminoglycans: re-creating, re-modeling and re-designing nature's longest or most complex carbohydrate chains.

  2013cited by this paper
• Fluorous supported modular synthesis of heparan sulfate oligosaccharides.

  2013cited by this paper
• Biologic drugs set to top 2012 sales

  2012cited by this paper
• Two opposing roles of O-glycans in tumor metastasis.

  2012cited by this paper
• Deciphering structural elements of mucin glycoprotein recognition.

  2012cited by this paper
• Modifications of glycans: biological significance and therapeutic opportunities.

  2012cited by this paper
• Glycans in Cancer

  2011cited by this paper
• Broad neutralization coverage of HIV by multiple highly potent antibodies

  2011cited by this paper
• A novel strategy for evasion of NK cell immunity by tumours expressing core2 O‐glycans

  2011cited by this paper
• Human Monoclonal Antibodies to Sialyl-Lewisa (CA19.9) with Potent CDC, ADCC, and Antitumor Activity

  2011cited by this paper
• Chemoenzymatic Synthesis of Homogeneous Ultralow Molecular Weight Heparins

  2011cited by this paper
• Elucidating glycosaminoglycan–protein–protein interactions using carbohydrate microarray and computational approaches

  2011cited by this paper
• Protein tyrosine O-glycosylation--a rather unexplored prokaryotic glycosylation system.

  2010cited by this paper
• Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.

  2010cited by this paper
• Chemoenzymatic Design of Heparan Sulfate Oligosaccharides*

  2010cited by this paper
• Multidimensional glycan arrays for enhanced antibody profiling.

  2010cited by this paper
• A systematic approach to protein glycosylation analysis: a path through the maze.

  2010cited by this paper
• Proteoglycomics: Recent Progress and Future Challenges

  2010cited by this paper
• Application of a Time-Varying Covariate Model to the Analysis of CA 19-9 as Serum Biomarker in Patients with Advanced Pancreatic Cancer

  2010cited by this paper
• An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.

  2009cited by this paper
• Structural Basis of Glycan Diversity

  2009cited by this paper
• Gangliosides in cell recognition and membrane protein regulation.

  2009cited by this paper
• The repertoire of glycan determinants in the human glycome.

  2009cited by this paper
• CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial.

  2008cited by this paper
• The Structure of Glycosaminoglycans and their Interactions with Proteins

  2008cited by this paper
• A Phase I Biodistribution and Pharmacokinetic Trial of Humanized Monoclonal Antibody Hu3s193 in Patients with Advanced Epithelial Cancers that Express the Lewis-Y Antigen

  2007cited by this paper
• High-throughput carbohydrate microarray profiling of 27 antibodies demonstrates widespread specificity problems.

  2007cited by this paper
• A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma.

  2006cited by this paper
• Role of the sulfation pattern of chondroitin sulfate in its biological activities and in the binding of growth factors.

  2006cited by this paper
• Features and functions of covalently linked proteins in fungal cell walls.

  2005cited by this paper
• Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy

  2005cited by this paper
• Three‐dimensional structures of carbohydrate determinants of Lewis system antigens: Implications for effective antibody targeting of cancer

  2005cited by this paper
• Glycans in cancer and inflammation — potential for therapeutics and diagnostics

  2005cited by this paper
• Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies

  2004cited by this paper
• Glycolipid-mediated cell-cell recognition in inflammation and nerve regeneration.

  2004cited by this paper
• Mouse monoclonal IgG 3 antibody detecting GD 3 ganglioside : A phase I trial in patients with malignant melanoma ( complement activation / inflammation / immunotherapy )

  2003cited by this paper
• O-glycosylation of EGF repeats: identification and initial characterization of a UDP-glucose: protein O-glucosyltransferase.

  2002cited by this paper
• A phase I trial of the single-chain immunotoxin SGN-10 (BR96 sFv-PE40) in patients with advanced solid tumors.

  2002cited by this paper
• Specific Molecular Interactions of Oversulfated Chondroitin Sulfate E with Various Heparin-binding Growth Factors

  2002cited by this paper
• Order out of chaos: assembly of ligand binding sites in heparan sulfate.

  2002cited by this paper
• Heparin-protein interactions.

  2002cited by this paper
• The cluster glycoside effect.

  2002cited by this paper
• Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial.

  2001cited by this paper
• Cartilage proteoglycans.

  2001cited by this paper
• Roles of O‐linked oligosaccharides in immune responses

  2000cited by this paper
• Structure and conformation of complex carbohydrates of glycoproteins, glycolipids, and bacterial polysaccharides.

  1999cited by this paper
• Protein O-mannosylation.

  1999cited by this paper
• 3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study.

  1998cited by this paper
• Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors.

  1998cited by this paper
• Synthetic ligands point to cell surface strategies

  1998cited by this paper
• Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group‐related antigens

  1997cited by this paper
• Polyvalent binding to carbohydrates immobilized on an insoluble resin.

  1997cited by this paper
• Glycosphingolipid antigens and cancer therapy.

  1997cited by this paper
• The O-Linked Fucose Glycosylation Pathway

  1997cited by this paper
• Treatment of advanced solid tumors with immunotoxin LMB–1: An antibody linked to Pseudomonas exotoxin

  1996cited by this paper
• Tandem Mass Spectrometry and Structural Elucidation of Glycopeptides from a Hydroxyproline-rich Plant Cell Wall Glycoprotein Indicate That Contiguous Hydroxyproline Residues Are the Major Sites of Hydroxyproline O-Arabinosylation (*)

  1995cited by this paper
• β‐Glucosylarginine: a new glucose‐protein bond in a self‐glucosylating protein from sweet corn

  1995cited by this paper
• Synthesis of O-glycan core 3: characterization of UDP-GlcNAc: GalNAc-R beta 3-N-acetyl-glucosaminyltransferase activity from colonic mucosal tissues and lack of the activity in human cancer cell lines.

  1995cited by this paper
• O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer.

  1994cited by this paper
• T cell recognition of carbohydrates on type II collagen

  1994cited by this paper
• Hyaluronan‐binding proteins in development, tissue homeostasis, and disease

  1993cited by this paper
• Hyaluronan and its binding proteins, the hyaladherins.

  1990cited by this paper
• Immunohistological detection of fucosyl-GM1 ganglioside in human lung cancer and normal tissues with monoclonal antibodies.

  1989cited by this paper
• Detection of a ganglioside antigen associated with small cell lung carcinomas using monoclonal antibodies directed against fucosyl-GM1.

  1986cited by this paper
• Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines.

  1986cited by this paper
• Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.

  1985cited by this paper
• Carbohydrate structures of glycoproteins and glycolipids as differentiation antigens, tumour-associated antigens and components of receptor systems

  1985cited by this paper
• Phase I Trial

  1983cited by this paper
• The effect of variation in molecular weight on the antigenicity of dextran in man.

  1958cited by this paper
• Some Configuration Requirements and Dimensions of the Combining Site on an Antibody to a Naturally Occuring Antigen1

  1954cited by this paper
• Microenvironment and Immunology Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-glycopeptide Epitopes

  year unknowncited by this paper

• Polymer-tethered glycosylated gold nanoparticles as versatile tools for bio-sensing.

  2026cites this paper
• Single-cell glycome and transcriptome profiling enabled by a library of anti-glycan antibodies.

  2025cites this paper
• Cancer-associated O-glycans and microbiome interactions in colorectal cancer: insights into tumor progression and immune evasion

  2025cites this paper
• Achieving cell-type selectivity in metabolic oligosaccharide engineering

  2025cites this paper
• The Biological Basis and Analyses of N-Glycan Microheterogeneity

  2025cites this paper
• Editor’s Choice Protein engineering strategies to develop lectins by design

  2025cites this paper
• Engineering glycosyltransferases into glycan binding proteins using a mammalian surface display platform

  2025cites this paper
• The Role of Glycans in Human Immunity—A Sweet Code

  2025cites this paper
• An Integrative Approach to Develop and Characterise Antibodies Against the Cancer Associated Antigen Sialyl Lewis A (CA 19-9)

  2025cites this paper
• A Single-Domain VNAR Nanobody Binds with High-Affinity and Selectivity to the Heparin Pentasaccharide Fondaparinux

  2025cites this paper
• Advances in glycan-specific biomimetic molecular recognition and its biomedical applications.

  2025cites this paper
• Defined Glycan Ligands for Detecting Rare l-Sugar-Binding Proteins

  2025cites this paper
• Biomimetic Recognition of SARS‐CoV‐2 Receptor‐Binding Domain N‐Glycans by an Antiviral Synthetic Receptor

  2025cites this paper
• Decoding Extracellular Protein Glycosylation in Human Health and Disease.

  2025cites this paper
• Mutant glycosidases for labeling sialoglycans with high specificity and affinity

  2025cites this paper
• Biomolecule‐responsive polymers and their bio‐applications

  2024cites this paper
• Reading the repertoire: Progress in adaptive immune receptor analysis using machine learning.

  2024cites this paper
• Screening and Characterization of Sialic Acid-Binding Variable Lymphocyte Receptors from Hagfish

  2024cites this paper
• The liquid lectin array detects compositional glycocalyx differences using multivalent DNA-encoded lectins on phage.

  2024cites this paper
• Detection Strategies for Sialic Acid and Sialoglycoconjugates

  2024cites this paper
• Optimization of glycopeptide enrichment techniques for the identification of clinical biomarkers

  2024cites this paper
• Lectin-modified drug delivery systems - Recent applications in the oncology field.

  2024cites this paper
• O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy.

  2024cites this paper
• The Glycocalyx: The Importance of Sugar Coating the Blood-Brain Barrier

  2024cites this paper
• Leveraging the biotechnological promise of the hagfish variable lymphocyte receptors: tools for aquatic microbial diseases.

  2024cites this paper
• Glycolanguage of the oral microbiota.

  2024cites this paper
• Enrichment methods of N-linked glycopeptides from human serum or plasma: A mini-review.

  2024cites this paper
• The Use of the Neoglycolipid-Based Oligosaccharide Microarray System in the Diagnosis of Endometriosis – Preliminary Study

  2024cites this paper
• Glycan-specific molecularly imprinted polymers towards cancer diagnostics: merits, applications, and future perspectives.

  2024cites this paper
• Antibody-lectin chimeras for glyco-immune checkpoint blockade

  2024cites this paper
• Magnetic dendritic mesoporous silica nanoparticles based integrated platform for rapid and efficient analysis of saccharides.

  2023cites this paper
• Towards Biomimetic Recognition of Glycans by Synthetic Receptors.

  2023cites this paper
• Dessert or Poison? The Roles of Glycosylation in Alzheimer's, Parkinson's, Huntington's Disease, and Amyotrophic Lateral Sclerosis

  2023cites this paper
• Functional binding of PD1 ligands predicts response to anti-PD1 treatment in patients with cancer

  2023cites this paper
• Smaller size packs a stronger punch - Recent advances in small antibody fragments targeting tumour-associated carbohydrate antigens

  2023cites this paper
• Mechanism of glycoform specificity and in vivo protection by an anti-afucosylated IgG nanobody

  2023cites this paper
• Carrier diversity and chemical ligations in the toolbox for designing tumor-associated carbohydrate antigens (TACAs) as synthetic vaccine candidates.

  2023cites this paper
• Anti-glycan monoclonal antibodies: Basic research and clinical applications.

  2023cites this paper
• Functional binding of PD1 ligands predicts response to anti-PD1 treatment in cancer patients

  2023cites this paper
• Mechanism of glycoform specificity and protection against antibody dependent enhancement by an anti-afucosylated IgG nanobody

  2023cites this paper
• (Glycan Binding) Activity-Based Protein Profiling in Cells Enabled by Mass Spectrometry-Based Proteomics

  2023cites this paper
• Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stroma

  2023cites this paper
• Worldwide Glycoscience Informatics Infrastructure: The GlySpace Alliance

  2022cites this paper
• Synthetic nanobodies as tools to distinguish IgG Fc glycoforms

  2022cites this paper
• Antibody-Drug Conjugates Targeting Tumor-Specific Mucin Glycoepitopes.

  2022cites this paper
• Molecular imprinting of glycoproteins: From preparation to cancer theranostics

  2022cites this paper
• Genetically encoded chemical crosslinking of carbohydrate

  2022cites this paper
• Photothermal Therapy of Neuroblastoma via Polysialic Acid-Targeting Nanomissiles.

  2022cites this paper
• Glycan microarrays from construction to applications.

  2022cites this paper
• Microarray-guided evaluation of the frequency, B-cell origins, and selectivity of human glycan-binding antibodies reveals new insights and novel antibodies

  2022cites this paper
• Development of a GalNAc-Tyrosine-Specific Monoclonal Antibody and Detection of Tyrosine O-GalNAcylation in Numerous Human Tissues and Cell Lines.

  2022cites this paper
• The role of IgG N-galactosylation in Spondyloarthritis

  2022cites this paper
• Imaging of antitubercular dimeric boronic acids at the mycobacterial cell surface by click-probe capture

  2022cites this paper
• Tools for mammalian glycoscience research.

  2022cites this paper
• Fabrication of self-healing magnetic nanoreceptors for glycoprotein via integrating boronate-affinity-oriented and sequential surface imprinting.

  2022cites this paper
• Generation of glycan-specific nanobodies.

  2022cites this paper
• Synthesis and Immunological Study of N-Glycan-Bacteriophage Qβ Conjugates Reveal Dominant Antibody Responses to the Conserved Chitobiose Core.

  2022cites this paper
• CarbArrayART: a new software tool for carbohydrate microarray data storage, processing, presentation, and reporting

  2022influential citation
• Selective Recognition of Carbohydrate Antigens by Germline Antibodies Isolated from AID Knockout Mice.

  2022cites this paper
• High-efficacy, high-manufacturability human VH domain antibody therapeutics from transgenic sources.

  2021cites this paper
• Resources and Methods for Engineering “Designer” Glycan-Binding Proteins

  2021cites this paper
• Strategies and Tactics for the Development of Selective Glycan-Binding Proteins.

  2021cites this paper
• Targeting the “Sweet Side” of Tumor with Glycan-Binding Molecules Conjugated-Nanoparticles: Implications in Cancer Therapy and Diagnosis

  2021cites this paper
• DNA-Encoded Multivalent Display of Protein Tetramers on Phage: Synthesis and In Vivo Aplications

  2021cites this paper
• Mass spectrometry and the cellular surfaceome.

  2021cites this paper
• Anti-glycan antibodies: roles in human disease.

  2021cites this paper
• PEI-assisted boronate affinity magnetic nanoparticle-based SELEX for efficient in vitro evolution of saponin-binding aptamers

  2021cites this paper
• Glycan Imaging Mass Spectrometry: Progress in Developing Clinical Diagnostic Assays for Tissues, Biofluids, and Cells.

  2021cites this paper
• Biomolecular recognition of the glycan neoantigen CA19-9 by distinct antibodies

  2021cites this paper
• Mass Spectrometry Imaging for Glycome in the Brain

  2021cites this paper
• Systematic Optimisation of Microtiter Plate Lectin Assay to Improve Sialic Acid Linkage Detection.

  2021cites this paper
• Glycosylation in Cervical Cancer: New Insights and Clinical Implications

  2021cites this paper
• Chemical Biology Tools for Modulating and Visualizing Gram-Negative Bacterial Surface Polysaccharides.

  2021cites this paper
• DNA-Encoded Multivalent Display of Chemically Modified Protein Tetramers on Phage: Synthesis and in Vivo Applications.

  2021cites this paper
• Preparing Molecularly Imprinted Nanoparticles of Saponins via Cooperative Imprinting Strategy.

  2020cites this paper
• The current structural glycome landscape and emerging technologies.

  2020cites this paper
• A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics

  2020cites this paper
• Integrating boronate affinity controllable-oriented surface imprinting nylon wire and pH-triggered allochroic-graphene oxide for ultrasensitive detection of glycoprotein

  2020cites this paper
• Targeting Glycans and Heavily Glycosylated Proteins for Tumor Imaging

  2020cites this paper
• Efficient Screening of Glycan-Specific Aptamers Using a Glycosylated Peptide as a Scaffold.

  2020cites this paper
• Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic Virotherapy

  2020influential citation
• Chemical synthesis and immunological evaluation of entirely carbohydrate conjugate Globo H-PS A1

  2020cites this paper
• High-mannose type N-glycans with core fucosylation and complex-type N-glycans with terminal neuraminic acid residues are unique to porcine islets

  2020cites this paper
• LectomeXplore, an update of UniLectin for the discovery of carbohydrate-binding proteins based on a new lectin classification

  2020cites this paper
• Structure, Function, and Therapeutic Use of IgM Antibodies

  2020cites this paper
• Directed Evolution of Therapeutic Antibodies Targeting Glycosylation in Cancer

  2020cites this paper
• A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry-based Glycoproteomics.

  2020cites this paper
• Chikungunya E2 Protein Produced in E. coli and HEK293-T Cells—Comparison of Their Performances in ELISA

  2020cites this paper
• Molecularly Imprinted Polymer Nanoparticles: An Emerging Versatile Platform for Cancer Therapy

  2020cites this paper
• Emergence and significance of carbohydrate-specific antibodies

  2020cites this paper
• Targeting Oligosaccharides and Glycoconjugates Using Superselective Binding Scaffolds

  2020cites this paper
• Dual boronate affinity nanoparticles-based plasmonic immunosandwich assay for specific and sensitive detection of ginsenosides.

  2020cites this paper
• Antibody-Mediated Endocytosis of Polysialic Acid Enables Intracellular Delivery and Cytotoxicity of a Glycan-Directed Antibody-Drug Conjugate.

  2019cites this paper
• Differential Expression of N- and O-glycans on HeLa Cells-Revealed by Direct Fluorescent Glycan Labeling with Recombinant Sialyltransferases

  2019cites this paper
• High-throughput synthesis and analysis of intact glycoproteins using SAMDI-MS.

  2019cites this paper
• Orthogonal dual molecularly imprinted polymer-based plasmonic immunosandwich assay: A double characteristic recognition strategy for specific detection of glycoproteins.

  2019cites this paper
• The challenges of glycan recognition with natural and artificial receptors.

  2019cites this paper
• The Histochemical Alterations of Mucin in Colorectal Carcinoma Quantified by Two Efficient Algorithms of Digital Image Analysis

  2019cites this paper
• Direct fluorescent glycan labeling with recombinant sialyltransferases

  2019cites this paper
• Precise Generation of Selective Surface-Confined Glycoprotein Recognition Sites

  2019cites this paper